Alternative Data for Caredx
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 75 | Sign up | Sign up | Sign up |
| Webpage traffic | 12,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 5 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,243 | Sign up | Sign up | Sign up |
| X Mentions | 3 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Caredx
CareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. The company is headquartered in South San Francisco, California.
| Price | $20.01 |
| Target Price | Sign up |
| Volume | 630,530 |
| Market Cap | $1.07B |
| Year Range | $11.57 - $20.63 |
| Dividend Yield | 0% |
| PE Ratio | 15.63 |
| Analyst Rating | 50% buy |
| Industry | Medical Devices |
In the news
 |
CareDx, Inc (CDNA) Q3 2025 Earnings Call TranscriptNovember 4 - SeekingAlpha |
 |
Is CareDx, Inc (NASDAQ:CDNA) Expensive For A Reason? A Look At Its Intrinsic ValueOctober 14 - Yahoo |
 |
CareDx (NASDAQ:CDNA) Upgraded to “Hold” at Wall Street ZenOctober 5 - ETF Daily News |
 |
CareDx (NASDAQ:CDNA) Earns “Buy” Rating from BTIG ResearchSeptember 24 - ETF Daily News |
|
Strs Ohio Invests $462,000 in CareDx, Inc. $CDNASeptember 23 - ETF Daily News |
|
Rhumbline Advisers Sells 1,817 Shares of CareDx, Inc. $CDNASeptember 20 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 100M | 31M | 69M | 1.7M | 6.8M | 0.280 |
| Q2 '25 | 87M | 29M | 58M | -8.6M | -5.7M | 0.100 |
| Q1 '25 | 85M | 28M | 56M | -10M | -3.1M | 0.100 |
| Q4 '24 | 87M | 28M | 58M | 78M | -7.2M | 0.180 |
| Q3 '24 | 83M | 28M | 55M | -7.4M | -5.6M | 0.140 |
Insider Transactions View All
| Novack Jeffrey Adam filed to sell 97,925 shares at $19.7. December 5 '25 |
| Novack Jeffrey Adam filed to sell 98,211 shares at $19.1. December 5 '25 |
| Novack Jeffrey Adam filed to sell 105,218 shares at $15.5. November 10 '25 |
| Novack Jeffrey Adam filed to sell 112,930 shares at $12.8. August 7 '25 |
| Maag Peter filed to sell 308,846 shares at $18.6. July 10 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$88.07 0% | 70 |
 |
Edwards LifesciencesEW |
$84.35 0% | 40 |
 |
Intuitive SurgicalISRG |
$535.07 0% | 71 |
 |
MedtronicMDT |
$96.76 0% | 53 |
 |
StrykerSYK |
$363.78 0% | 53 |
Read more about Caredx (CDNA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, x mentions, news mentions & customer reviews.
FAQ - Caredx
The Market Cap of Caredx is $1.07B.
As of today, Caredx's PE (Price to Earnings) ratio is 15.63.
Currently, the price of one share of Caredx stock is $20.01.
The CDNA stock price chart above provides a comprehensive visual representation of Caredx's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Caredx shares. Our platform offers an up-to-date CDNA stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Caredx (CDNA) does not offer dividends to its shareholders. Investors interested in Caredx should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Caredx are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
